These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5299837)

  • 1. Brain barrier to 5-HTP.
    Engelman K; Lovenberg W; Sjoerdsma A
    N Engl J Med; 1968 Feb; 278(5):281. PubMed ID: 5299837
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain barrier to 5-HTP.
    Glassman A
    N Engl J Med; 1968 Feb; 278(5):281. PubMed ID: 5299836
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-Hydroxytryptophan: a clinically-effective serotonin precursor.
    Birdsall TC
    Altern Med Rev; 1998 Aug; 3(4):271-80. PubMed ID: 9727088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative penetration of L-dopa and 5-HTP through the brain barrier using dimethyl sulfoxide.
    De la Torre JC
    Experientia; 1970 Oct; 26(10):1117-8. PubMed ID: 5312418
    [No Abstract]   [Full Text] [Related]  

  • 5. Impaired permeability of the blood-cerebrospinal fluid barrier in hyperphenylalaninaemia.
    Piel N; Lane JD; Hüther G; Neuhoff V
    Neuropediatrics; 1982 May; 13(2):88-92. PubMed ID: 6982428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers.
    Agren H; Reibring L; Hartvig P; Tedroff J; Bjurling P; Hörnfeldt K; Andersson Y; Lundqvist H; Långström B
    Acta Psychiatr Scand; 1991 Jun; 83(6):449-55. PubMed ID: 1882697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects.
    Byerley WF; Judd LL; Reimherr FW; Grosser BI
    J Clin Psychopharmacol; 1987 Jun; 7(3):127-37. PubMed ID: 3298325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carbidopa on the cerebral accumulation of exogenous L-5-hydroxytryptophan in mice.
    Magnussen I
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):199-202. PubMed ID: 6334429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oral 5-HTP administration on 5-HTP and 5-HT immunoreactivity in monoaminergic brain regions of rats.
    Lynn-Bullock CP; Welshhans K; Pallas SL; Katz PS
    J Chem Neuroanat; 2004 May; 27(2):129-38. PubMed ID: 15121217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of 5-HTP in the treatment of Down's syndrome.
    Weise P; Koch R; Shaw KN; Rosenfeld MJ
    Pediatrics; 1974 Aug; 54(2):165-8. PubMed ID: 4277102
    [No Abstract]   [Full Text] [Related]  

  • 11. Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat.
    Nakatani Y; Sato-Suzuki I; Tsujino N; Nakasato A; Seki Y; Fumoto M; Arita H
    Eur J Neurosci; 2008 May; 27(9):2466-72. PubMed ID: 18445233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incapacity of 5-hydroxytryptophan to act against the depression of tumor-resisting power of host animal which is induced by whole body x-irradiation].
    Nakamura W; Nishimoto Y
    C R Seances Soc Biol Fil; 1975; 169(2):468-72. PubMed ID: 126790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man.
    Magnussen I; Jensen TS; Rand JH; Van Woert MH
    Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):184-9. PubMed ID: 6175178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HTP hypothesis of schizophrenia.
    Fukuda K
    Med Hypotheses; 2014 Jan; 82(1):20-3. PubMed ID: 24280562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
    Takahashi S; Takahashi R; Masumura I; Miike A
    Folia Psychiatr Neurol Jpn; 1976; 30(4):461-73. PubMed ID: 1087913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptophan: A precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology.
    Sharma A; Castellani RJ; Smith MA; Muresanu DF; Dey PK; Sharma HS
    Int Rev Neurobiol; 2019; 146():1-44. PubMed ID: 31349924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-5-hydroxytryptophan therapy in myoclonus: discussion.
    Adv Neurol; 1979; 26():117-22. PubMed ID: 316274
    [No Abstract]   [Full Text] [Related]  

  • 18. L-5-hydroxytryptophan does not stimulate LH secretion directly from the pituitary in patients with gonadotrophin releasing hormone deficiency.
    Lado-Abeal J; Graña M; Rey C; Cabezas-Cerrato J
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):203-7. PubMed ID: 9828908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant.
    van Praag HM; Korf J; Dols LC; Schut T
    Psychopharmacologia; 1972; 25(1):14-21. PubMed ID: 4556909
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.
    Turner EH; Loftis JM; Blackwell AD
    Pharmacol Ther; 2006 Mar; 109(3):325-38. PubMed ID: 16023217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.